A systematic review by Koniali et al. identified young age, ER negativity, HER-2 receptor positivity, high tumor stage, size, histological grade, high Ki67 labeling index, and nodal involvement as independent risk factors for BM in patients with BC [21]. This evidence concerns the gene MKI67 and breast cancer.